Parabilis Medicines, Inc. (PBLS) research

Parabilis Medicines, Inc.
ShareXLinkedInReddit
Sector
Healthcare
Industry
Biotechnology
Last price
$36.88
As of
SHARE THIS CARD

Share the PBLS intelligence card

A branded snapshot of PBLS: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion PBLS intelligence card preview
Post to X
LIVE TERMINAL

See PBLS live in the terminal

Track PBLS's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live PBLS terminal, free

Active signals for PBLS

FREE, NO ACCOUNT

Every signal on PBLS, as it fires

New filings, 13F moves and cross asset signals on PBLS land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in PBLS (2026Q2)

Manager / securityMarket value% portfolioQoQ
TWO SIGMA INVESTMENTS, LPCUSIP 698955101 · 2026Q2$239K0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, PBLS

Related tickers

See more PBLS signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to PBLSand get the insider, 13F, options, and confluence read in one view.

Open the live PBLS terminal, free